PathCrisp-Sal offers ultra-sensitive, rapid detection of Salmonella in complex food matrices using a LAMP-integrated CRISPR-Cas12 assay. It's capable of identifying low pathogen copies within 4 hours, overcoming challenges in matrices like chocolate. Suitable for point-of-need deployment.
PathCrisp-Sal is an innovative CRISPR-Cas12 assay integrated with Loop Mediated Isothermal Amplification (LAMP) designed for ultra-sensitive and rapid detection of Salmonella spp. in complex food matrices, such as chocolate. Traditional detection methods struggle with high-fat, low-water content foods, but PathCrisp-Sal's isothermal workflow and tolerance for matrix inhibitors allow for effective testing directly from crude extracts. Its rapid detection capability (≤4 hours) and point-of-need deployment feature make it an ideal solution for industries requiring quick pathogen detection.
PathCrisp-Sal has reached Technology Readiness Level 4, having been validated in clinical samples and complex food matrices such as milk. Future validation studies will focus on detecting Salmonella in chocolate, with improvements in extraction methods and reduction of false negatives being explored.
CRISPR Therapeutics is a biotechnology company dedicated to developing gene-based medicines using CRISPR/Cas9 technology, with a focus on serious diseases like blood disorders, cancer, and autoimmune conditions.